AnalyzeDirect Uchida H, Suzuki T, Graff-Guerrero A, Mulsant BH, Pollock BG, Arenovich T, Rajji TK, Mamo DC. Therapeutic window for striatal dopamine D2/3 receptor occupancy in older patients with schizophrenia: a pilot PET study. Am J Geriatr Psychiatry. October 2012.
Publication Date
October 2012
How Analyze was Used
“An ROI analysis was completed by one of the investigators (HU) using the Analyze software, version 6.0 (AnalyzeDirect, Lenexa, KS).”
Keywords
Age Factors
Aged
Dopamine
Humans
Middle Aged
Mental Health
Positron Emission Tomography (PET)
Pilot Projects
Putamen
Raclopride
Receptors, Dopamine D2
Risperidone
Schizophrenia
Treatment Outcome
Author Affiliation(s)
Geriatric Mental Health Program, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. (HU, TS, AGG, BHM, BGP, TKR, DCM)
Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan. (HU, TS)
Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. (TS, AGG, BHM, BGP, TKR, DCM)
Multimodal Imaging Group, PET Centre, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. (TS, AGG, TKR, DCM)
Biostatistical Consulting Service, Clinical Research Department, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. (TA)
ID# 2692
Tags: Age Factors, Aged, Dopamine, Dopamine D2 Receptors, Humans, Mental Health, Middle Aged, Pilot Projects, Positron Emission Tomography (PET), Putamen, Raclopride, Risperidone, Schizophrenia, Treatment Outcome